Paul Tudor Jones's SION Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 22,575 shares of Sionna Therapeutics, Inc. (SION) worth $993,074, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in SION, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Sionna Therapeutics (SION) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sionna Therapeutics (SION) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +22,575 | New Buy | 22,575 | $43.99 |
Paul Tudor Jones's Sionna Therapeutics Investment FAQs
Paul Tudor Jones first purchased Sionna Therapeutics, Inc. (SION) in Q2 2026, acquiring 22,575 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Sionna Therapeutics, Inc. (SION) for 1 quarters since Q2 2026.
Paul Tudor Jones's largest addition to Sionna Therapeutics, Inc. (SION) was in Q2 2026, adding 22,575 shares worth $993,074.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 22,575 shares of Sionna Therapeutics, Inc. (SION), valued at approximately $993,074.
As of the Q2 2026 filing, Sionna Therapeutics, Inc. (SION) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Sionna Therapeutics, Inc. (SION) was 22,575 shares, as reported at the end of Q2 2026.